The overexpression of BMP-2 may lead to renal injury and hypertension in CKD patients [37], whereas the elevated concentration of TGF-β1 may be the main pathogenic factor driving glomerular and tubulointerstitial fibrosis in the kidney [38, 39]. Here, TGFB1 is linked to hypertensive disorder.